Additionally, the authors suggest that modulating the expression of Slco1a4 by targeting the TGF- β/ALK5 pathway may be a potential strategy to increase statin levels in the brain and reduce stroke volume [66]. The gene discussed is TGFBR1; the disease is Stroke.